"Urethral Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.
| Descriptor ID |
D014523
|
| MeSH Number(s) |
C04.588.945.947.945 C12.758.820.937 C12.777.767.601 C13.351.937.820.890 C13.351.968.767.601
|
| Concept/Terms |
Urethral Neoplasms- Urethral Neoplasms
- Neoplasms, Urethral
- Neoplasm, Urethral
- Urethral Neoplasm
- Urethra Neoplasms
- Neoplasm, Urethra
- Neoplasms, Urethra
- Urethra Neoplasm
Cancer of Urethra- Cancer of Urethra
- Urethra Cancers
- Urethra Cancer
- Cancer, Urethra
- Cancers, Urethra
- Urethral Cancer
- Cancer, Urethral
- Cancers, Urethral
- Urethral Cancers
- Cancer of the Urethra
|
Below are MeSH descriptors whose meaning is more general than "Urethral Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urethral Neoplasms".
This graph shows the total number of publications written about "Urethral Neoplasms" by people in this website by year, and whether "Urethral Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urethral Neoplasms" by people in Profiles.
-
D'Amico MJ, Shumaker AD, Chung PH. Urethral Cancer After Urethroplasty: A Case Report and Review of the Literature. Urology. 2022 11; 169:218-225.
-
Bryce AH, Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, McCullough AE, Hunt KS, Ritacca NR, Barrett MT, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, Stanton ML, Cheville J, Swanson S, Schneider DE, McWilliams RR, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Cuyugan L, McDonald J, Adkins J, Mastrian SD, Von Hoff DD, Craig DW, Stewart AK, Carpten JD. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. Clin Genitourin Cancer. 2017 08; 15(4):e727-e734.
-
Champ CE, Hegarty SE, Shen X, Mishra MV, Dicker AP, Trabulsi EJ, Lallas CD, Gomella LG, Hyslop T, Showalter TN. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology. 2012 Aug; 80(2):374-81.
-
Trabulsi EJ, Hoffman-Censits J. Chemotherapy for penile and urethral carcinoma. Urol Clin North Am. 2010 Aug; 37(3):467-74.
-
Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology. 2006 Dec; 68(6):1164-8.
-
Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol. 2003 Mar; 169(3):961-3.